This agent induced a G2/M cell cycle block through a reduction in cell cycle progression signals (FOXM1, KIS, Cdc25B, Cyclin D1, Cyclin A, and Aurora-B), resulting in inhibition of leukemia cell proliferation [1]. The gene discussed is CDC25B; the disease is leukemia.